U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907757) titled 'Colchicine in Pulmonary Artery Hypertension Patients' on Oct. 26.
Brief Summary: This study evaluates the efficacy of colchicine in improving cardiopulmonary function for patients diagnosed with Pulmonary Arterial Hypertension (PAH), a condition characterized by elevated pulmonary pressure that impairs right ventricular performance.
While current therapeutic interventions target pulmonary vasculature, right ventricular decline remains a clinical challenge. Colchicine, an anti-inflammatory agent typically indicated for gout and cardiovascular conditions, has demonstrated potential in preclinical models to mitigate mechanisms contrib...